Nabriva Therapeutics to Present Data at ASM Microbe Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin) for injec...
Nabriva Therapeutics plc - Ordinary Shares (NBRV)
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.nabriva.com/investor-relations
Company Research
Source: GlobeNewswire
DUBLIN, Ireland, June 21, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced that it will present data at ASM Microbe 2019 to be held June 20 - 24 in San Francisco, CA. “At Nabriva, we are committed to the fight against the growing threat of antimicrobial resistance in CABP and cUTIs and bringing novel anti-infective agents to patients in need. The ASM delegation is an important partner in this struggle,” said Jennifer Schranz, M.D., Chief Medical Officer of Nabriva Therapeutics. “At ASM Microbe, we will present additional data from our phase 3 lefamulin and CONTEPO clinical studies that further support efficacy by pathogen for CABP and cUTI, respectively.” Highlights of the data to be presented at ASM Microbe 2019 include: Friday June 21st Session: P404 – CIV01 – Clinical Studies of Adult Infectious Dise
Show less
Read more
Impact Snapshot
Event Time:
NBRV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBRV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBRV alerts
High impacting Nabriva Therapeutics plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics